Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Glutamatergic synapse (mmu04724)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
1500003O
03Rik
KLA  ATP  ATP+KLA
 NM_019769 RIKEN cDNA 1500003O03 gene (1500003O03Rik), mRNA [NM_019769] KLA .92 .89 .89 .86 .85 .92 1.08
ATP 1.01 1.16 1.16 1.53 1.70 3.33 2.09
KLA/ATP .89 .97 .93 1.17 1.19 2.86 2.57
2010110P
09Rik
KLA  ATP  ATP+KLA
 NM_027363 RIKEN cDNA 2010110P09 gene (2010110P09Rik), mRNA [NM_027363] KLA .99 .98 1.02 .99 .94 1.01 1.01
ATP 1.04 1.05 .97 1.05 .95 .98 .95
KLA/ATP .93 1.00 1.02 .97 1.01 .96 .97
AK036998
KLA  ATP  ATP+KLA
 AK036998 adult female vagina cDNA, RIKEN full-length enriched library, clone:9930034M05 product:unclassifiable, full insert sequence. [AK036998] KLA 1.43 1.09 .89 .79 .96 .97 .71
ATP 1.04 1.04 .71 .64 .90 .82 .82
KLA/ATP 1.34 1.23 1.01 .89 1.10 .82 .75
AK157575
KLA  ATP  ATP+KLA
 AK157575 activated spleen cDNA, RIKEN full-length enriched library, clone:F830224H04 product:unclassifiable, full insert sequence. [AK157575] KLA .73 .72 .68 .76 .91 .91 1.02
ATP 2.85 3.50 5.51 5.90 1.67 .96 .94
KLA/ATP 1.11 1.56 2.49 2.64 1.45 1.05 .95
Adcy1
KLA  ATP  ATP+KLA
 BC050125 adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] KLA 1.05 1.03 .98 1.04 1.05 1.09 1.10
ATP .90 1.02 .99 .97 1.03 .95 1.01
KLA/ATP .99 1.04 .90 .98 .98 1.00 1.03
Adcy1
KLA  ATP  ATP+KLA
 NM_009622 adenylate cyclase 1 (Adcy1), mRNA [NM_009622] KLA 1.07 1.02 1.06 1.07 1.03 1.02 1.01
ATP 1.02 1.04 1.00 .99 .99 .95 .97
KLA/ATP .97 1.05 1.02 1.05 1.01 .98 1.05
Adcy2
KLA  ATP  ATP+KLA
 NM_153534 adenylate cyclase 2 (Adcy2), mRNA [NM_153534] KLA .79 .82 .83 .73 .61 .66 .90
ATP 1.10 1.09 1.02 1.04 .88 .58 .53
KLA/ATP .84 .87 .77 .75 .68 .60 .43
Adcy3
KLA  ATP  ATP+KLA
 NM_138305 adenylate cyclase 3 (Adcy3), mRNA [NM_138305] KLA .84 .84 .83 .78 .66 .55 .49
ATP 1.09 1.05 .89 1.02 .84 .62 1.52
KLA/ATP .93 .87 .75 .85 .66 .83 .77
Adcy4
KLA  ATP  ATP+KLA
 NM_080435 adenylate cyclase 4 (Adcy4), mRNA [NM_080435] KLA 1.05 1.07 .96 1.00 1.04 1.05 1.05
ATP 1.02 1.05 1.02 1.48 1.37 1.08 1.09
KLA/ATP 1.00 1.05 .91 1.19 1.35 1.27 1.08
Adcy5
KLA  ATP  ATP+KLA
 NM_001012765 adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] KLA 1.06 1.00 .97 1.01 1.03 .95 .93
ATP .95 1.08 1.08 1.07 .97 1.03 .97
KLA/ATP .97 .92 1.04 .99 .91 .96 1.04
Adcy6
KLA  ATP  ATP+KLA
 NM_007405 adenylate cyclase 6 (Adcy6), mRNA [NM_007405] KLA 1.10 1.16 1.16 1.09 1.08 1.06 .99
ATP 1.05 .97 1.08 1.12 1.08 1.08 1.04
KLA/ATP 1.14 1.20 1.29 1.30 1.25 1.11 1.07
Adcy7
KLA  ATP  ATP+KLA
 NM_001037724 adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] KLA .43 .39 .35 .32 .45 .72 .84
ATP .90 .84 .62 .41 .53 .42 .94
KLA/ATP .39 .34 .23 .17 .41 .34 .67
Adcy7
KLA  ATP  ATP+KLA
 NM_007406 adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] KLA .51 .52 .48 .41 .59 .81 .99
ATP 1.01 1.02 .62 .52 .53 .38 .98
KLA/ATP .53 .48 .30 .27 .42 .36 .65
Adcy8
KLA  ATP  ATP+KLA
 NM_009623 adenylate cyclase 8 (Adcy8), mRNA [NM_009623] KLA 1.00 1.00 1.07 .97 1.04 .98 1.02
ATP 1.04 1.05 1.14 1.03 .99 1.00 .97
KLA/ATP 1.05 1.04 1.00 1.03 .98 .94 .96
Adcy9
KLA  ATP  ATP+KLA
 NM_009624 adenylate cyclase 9 (Adcy9), mRNA [NM_009624] KLA .18 .15 .13 .15 .17 .19 .33
ATP 1.33 1.16 .97 .98 .62 .56 .86
KLA/ATP .19 .16 .17 .18 .20 .25 .38
Adrbk1
KLA  ATP  ATP+KLA
 NM_130863 adrenergic receptor kinase, beta 1 (Adrbk1), mRNA [NM_130863] KLA .90 .84 .99 1.05 1.52 1.69 1.78
ATP 1.07 1.17 .92 1.19 .76 .60 1.08
KLA/ATP .93 .98 .66 .95 .63 .76 1.59
BB548379
KLA  ATP  ATP+KLA
 BB548379 gb|BB548379 RIKEN full-length enriched, 2 days pregnant adult female oviduct Mus musculus cDNA clone E230007L20 3. [BB548379] KLA .98 1.05 1.00 .99 1.04 1.04 1.05
ATP 1.01 .98 1.01 1.02 .98 1.08 .92
KLA/ATP .98 1.06 1.03 1.03 1.00 1.00 .99
BI102035
KLA  ATP  ATP+KLA
 BI102035 gb|602887753F1 NCI_CGAP_Kid14 Mus musculus cDNA clone IMAGE:5043156 5, mRNA sequence [BI102035] KLA 1.00 .99 1.05 .97 1.03 1.04 1.06
ATP .99 .97 1.02 1.06 1.02 .98 1.02
KLA/ATP 1.05 .98 1.13 1.03 1.00 1.08 1.33
Cacna1a
KLA  ATP  ATP+KLA
 NM_007578 calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (Cacna1a), mRNA [NM_007578] KLA .71 .66 .61 .63 .60 .71 .72
ATP 1.07 1.04 .89 1.08 .71 .56 .75
KLA/ATP .71 .72 .85 .69 .64 .63 .68
Cacna1d
KLA  ATP  ATP+KLA
 NM_001083616 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] KLA 1.57 1.58 2.50 3.62 4.55 2.93 .99
ATP 1.12 .99 .97 .94 .75 1.71 1.48
KLA/ATP 1.47 1.51 1.82 1.56 1.67 2.93 4.60
Cacna1d
KLA  ATP  ATP+KLA
 NM_028981 calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] KLA 1.20 1.26 1.43 1.62 2.07 1.66 1.00
ATP 1.03 1.03 .97 .97 .93 1.20 1.26
KLA/ATP 1.16 1.12 1.10 1.14 1.08 1.44 2.56
Dlg4
KLA  ATP  ATP+KLA
 NM_007864 discs, large homolog 4 (Drosophila) (Dlg4), transcript variant 1, mRNA [NM_007864] KLA .97 .97 .95 .93 .99 1.01 1.03
ATP .98 1.00 .95 .96 .93 .98 1.01
KLA/ATP .96 .97 .95 .93 .91 1.00 .93
Dlgap1
KLA  ATP  ATP+KLA
 AK033901 adult male diencephalon cDNA, RIKEN full-length enriched library, clone:9330112K10 product:DISKS LARGE-ASSOCIATED PROTEIN 1 (DAP-1) (GUANYLATE KINASE-ASSOCIATED PROTEIN) (RGKAP) (SAP90/PSD-95-ASSOCIATED PROTEIN 1) (SAPAP1) (PSD- 95/SAP90 KLA .93 .97 1.01 .94 .94 1.02 1.05
ATP 1.00 1.02 1.10 .96 .96 1.06 .99
KLA/ATP .92 .98 1.07 .99 .99 .95 .98
Dlgap1
KLA  ATP  ATP+KLA
 NM_177639 discs, large (Drosophila) homolog-associated protein 1 (Dlgap1), mRNA [NM_177639] KLA .98 1.00 1.02 .94 .99 .95 1.01
ATP .98 1.00 .97 1.05 1.03 .93 .93
KLA/ATP .93 1.11 1.05 1.00 1.06 1.01 .95
Gls2
KLA  ATP  ATP+KLA
 NM_001033264 glutaminase 2 (liver, mitochondrial) (Gls2), nuclear gene encoding mitochondrial protein, mRNA [NM_001033264] KLA 1.03 .98 1.02 .97 .98 .88 .80
ATP .94 1.01 1.04 1.08 1.26 1.20 .87
KLA/ATP .95 .98 1.15 1.02 1.29 .99 .87
Glul
KLA  ATP  ATP+KLA
 NM_008131 glutamate-ammonia ligase (glutamine synthetase) (Glul), mRNA [NM_008131] KLA .58 .54 .47 .41 .30 .31 .40
ATP .96 .99 1.46 2.55 2.16 2.88 1.34
KLA/ATP .57 .56 .83 1.52 1.27 1.20 .97
Glul
KLA  ATP  ATP+KLA
 X16314 gb|M.musculus mRNA for glutamine synthetase. [X16314] KLA .86 .95 .79 .87 .78 .99 .83
ATP .95 1.03 1.09 1.27 1.14 1.37 1.00
KLA/ATP .88 .97 .89 1.12 1.01 1.19 .91
Gnai1
KLA  ATP  ATP+KLA
 NM_010305 guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] KLA .95 1.01 1.01 1.00 1.09 1.10 1.08
ATP 1.06 1.06 .99 1.15 1.02 .94 .99
KLA/ATP 1.02 1.04 .99 1.16 1.01 1.02 1.13
Gnai2
KLA  ATP  ATP+KLA
 NM_008138 guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] KLA .74 .79 .82 .74 .91 .97 1.10
ATP 1.07 1.16 .78 1.12 .78 .48 .82
KLA/ATP .91 .81 .53 .80 .60 .68 .87
Gnai3
KLA  ATP  ATP+KLA
 NM_010306 guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] KLA 1.23 1.24 1.14 1.06 .99 1.15 1.09
ATP .96 .93 .86 .64 1.34 2.02 1.35
KLA/ATP 1.20 1.24 .97 .76 1.21 1.62 1.17
Gnao1
KLA  ATP  ATP+KLA
 NM_001113384 guanine nucleotide binding protein, alpha O (Gnao1), transcript variant B, mRNA [NM_001113384] KLA .95 .98 1.03 1.00 1.02 1.02 .99
ATP .95 1.02 1.01 1.08 .99 .97 .95
KLA/ATP 1.05 1.04 1.10 .99 1.01 .98 1.03
Gnao1
KLA  ATP  ATP+KLA
 NM_010308 guanine nucleotide binding protein, alpha O (Gnao1), transcript variant A, mRNA [NM_010308] KLA .98 .96 1.00 .97 .96 .97 1.01
ATP 1.12 .99 1.05 .87 .97 1.02 1.01
KLA/ATP .93 1.00 .99 1.01 1.05 1.07 .98
Gnaq
KLA  ATP  ATP+KLA
 NM_008139 guanine nucleotide binding protein, alpha q polypeptide (Gnaq), mRNA [NM_008139] KLA .82 .82 .69 .64 .60 .55 .55
ATP 1.06 1.02 .87 .67 .50 .66 .57
KLA/ATP .82 .79 .66 .55 .41 .33 .48
Gnas
KLA  ATP  ATP+KLA
 AF107847 neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] KLA 1.04 .94 1.00 1.05 1.04 .98 1.00
ATP .98 .97 .96 1.00 .99 .98 1.02
KLA/ATP 1.04 1.02 .96 .95 1.01 .96 1.01
Gnas
KLA  ATP  ATP+KLA
 AK017423 10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] KLA .85 1.08 .97 .92 1.05 1.03 1.08
ATP .99 1.30 2.11 1.73 1.23 1.01 1.02
KLA/ATP .96 1.06 1.58 1.34 1.29 1.05 .91
Gnas
KLA  ATP  ATP+KLA
 NM_001077510 GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] KLA .99 1.03 .97 .91 1.03 .95 .97
ATP 1.04 1.19 1.15 1.61 1.24 .91 1.00
KLA/ATP 1.06 .97 1.01 1.46 1.04 .85 1.01
Gnas
KLA  ATP  ATP+KLA
 S49980 gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] KLA .91 .88 1.03 .87 .90 .84 1.01
ATP 1.16 1.22 1.02 1.55 1.16 .80 .99
KLA/ATP 1.01 1.13 .86 1.12 .97 .85 1.08
Gnb1
KLA  ATP  ATP+KLA
 NM_008142 guanine nucleotide binding protein (G protein), beta 1 (Gnb1), mRNA [NM_008142] KLA 1.11 1.18 1.22 1.19 1.29 1.32 1.76
ATP 1.02 1.09 .84 .99 .97 .89 1.22
KLA/ATP 1.20 1.25 .85 1.01 .86 .91 1.57
Gnb2
KLA  ATP  ATP+KLA
 NM_010312 guanine nucleotide binding protein (G protein), beta 2 (Gnb2), mRNA [NM_010312] KLA .94 .98 .94 1.08 1.23 1.32 1.16
ATP 1.04 .96 .59 .64 .59 .76 1.18
KLA/ATP 1.02 .84 .62 .64 .61 .89 1.36
Gnb3
KLA  ATP  ATP+KLA
 NM_013530 guanine nucleotide binding protein (G protein), beta 3 (Gnb3), mRNA [NM_013530] KLA .99 1.00 .98 1.03 .94 .99 .96
ATP 1.01 1.02 .97 .95 1.01 .97 .92
KLA/ATP .99 1.02 1.02 .98 .99 .85 .99
Gnb4
KLA  ATP  ATP+KLA
 AK165084 2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330002E21 product:guanine nucleotide binding protein, beta 4, full insert sequence [AK165084] KLA 4.61 4.10 4.23 2.41 2.25 1.59 .93
ATP 1.21 1.17 1.04 .81 2.92 1.50 1.03
KLA/ATP 5.86 6.56 3.60 1.68 5.62 3.00 1.37
Gnb4
KLA  ATP  ATP+KLA
 NM_013531 guanine nucleotide binding protein (G protein), beta 4 (Gnb4), mRNA [NM_013531] KLA 8.41 8.09 10.57 9.44 6.06 2.97 .92
ATP 1.07 1.04 1.09 .87 1.48 2.10 1.18
KLA/ATP 8.14 8.93 9.12 7.69 5.03 5.11 2.37
Gnb5
KLA  ATP  ATP+KLA
 NM_010313 guanine nucleotide binding protein (G protein), beta 5 (Gnb5), transcript variant 1, mRNA [NM_010313] KLA .68 .75 .67 .66 .53 .50 .65
ATP 1.03 1.08 1.09 1.14 .72 .54 .77
KLA/ATP .73 .70 .71 .73 .61 .65 .58
Gng10
KLA  ATP  ATP+KLA
 NM_025277 guanine nucleotide binding protein (G protein), gamma 10 (Gng10), mRNA [NM_025277] KLA .95 .95 .86 .83 .70 .53 .43
ATP .93 1.03 1.17 1.21 .97 .60 .52
KLA/ATP .84 .91 .93 .99 .79 .47 .24
Gng11
KLA  ATP  ATP+KLA
 NM_025331 guanine nucleotide binding protein (G protein), gamma 11 (Gng11), mRNA [NM_025331] KLA 1.30 1.26 1.44 1.54 1.26 1.42 1.90
ATP .88 .78 1.26 1.14 .90 .64 1.60
KLA/ATP 1.11 1.18 1.81 1.55 1.81 1.75 3.05
Gng12
KLA  ATP  ATP+KLA
 NM_025278 guanine nucleotide binding protein (G protein), gamma 12 (Gng12), mRNA [NM_025278] KLA 2.21 2.23 2.48 2.62 2.47 2.28 1.68
ATP 1.02 1.02 1.09 1.10 1.20 1.32 1.01
KLA/ATP 2.10 2.17 2.38 2.40 1.91 1.60 1.77
Gng13
KLA  ATP  ATP+KLA
 NM_022422 guanine nucleotide binding protein (G protein), gamma 13 (Gng13), mRNA [NM_022422] KLA 1.04 1.04 .94 1.00 1.00 1.05 .96
ATP 1.07 1.05 1.02 .94 .98 1.03 1.01
KLA/ATP 1.01 .99 1.05 1.01 1.01 .98 1.02
Gng2
KLA  ATP  ATP+KLA
 NM_010315 guanine nucleotide binding protein (G protein), gamma 2 (Gng2), transcript variant 1, mRNA [NM_010315] KLA .79 .81 .81 .82 .67 .57 .75
ATP 1.02 1.01 1.13 1.35 1.48 1.01 1.31
KLA/ATP .79 .86 .97 1.05 1.29 1.00 .84
Gng3
KLA  ATP  ATP+KLA
 NM_010316 guanine nucleotide binding protein (G protein), gamma 3 (Gng3), mRNA [NM_010316] KLA 1.00 .98 1.02 .95 .99 1.00 1.06
ATP .98 1.05 .99 1.03 1.05 1.03 .97
KLA/ATP 1.01 1.00 1.07 1.01 1.04 1.04 1.05
Gng4
KLA  ATP  ATP+KLA
 NM_010317 guanine nucleotide binding protein (G protein), gamma 4 (Gng4), mRNA [NM_010317] KLA 1.27 1.26 1.47 1.30 1.15 1.13 .82
ATP 1.05 .97 1.07 1.62 3.97 3.46 1.24
KLA/ATP 1.35 1.32 1.37 1.35 1.64 2.18 1.56
Gng5
KLA  ATP  ATP+KLA
 NM_010318 guanine nucleotide binding protein (G protein), gamma 5 (Gng5), mRNA [NM_010318] KLA .94 .84 .80 1.12 .98 1.11 1.29
ATP 1.07 1.01 1.07 1.05 1.17 1.52 1.01
KLA/ATP .83 .94 1.27 1.17 1.19 1.35 1.36
Gng7
KLA  ATP  ATP+KLA
 NM_001038655 guanine nucleotide binding protein (G protein), gamma 7 (Gng7), transcript variant 1, mRNA [NM_001038655] KLA .92 .96 .87 .91 .83 .98 .98
ATP 1.04 1.06 .98 .95 .81 .77 .75
KLA/ATP .97 .95 .81 .91 .79 .77 .81
Gng8
KLA  ATP  ATP+KLA
 NM_010320 guanine nucleotide binding protein (G protein), gamma 8 (Gng8), mRNA [NM_010320] KLA .93 .93 .95 .96 .90 .88 1.09
ATP .95 .90 1.01 .92 1.04 1.01 1.05
KLA/ATP .97 1.03 .99 .90 1.10 .99 1.04
Gngt1
KLA  ATP  ATP+KLA
 NM_010314 guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 (Gngt1), mRNA [NM_010314] KLA 1.06 .99 .95 .98 1.03 1.10 .98
ATP .96 1.02 1.03 1.03 .94 1.06 .95
KLA/ATP .98 1.03 1.04 1.04 1.01 1.03 1.01
Gria1
KLA  ATP  ATP+KLA
 NM_008165 glutamate receptor, ionotropic, AMPA1 (alpha 1) (Gria1), transcript variant 2, mRNA [NM_008165] KLA .97 1.02 1.02 1.01 1.03 1.02 1.11
ATP 1.03 .97 1.05 1.03 1.01 1.01 1.01
KLA/ATP 1.02 .99 1.01 1.06 1.15 1.06 1.05
Gria2
KLA  ATP  ATP+KLA
 BC048248 glutamate receptor, ionotropic, AMPA2 (alpha 2), mRNA (cDNA clone MGC:54603 IMAGE:6494013), complete cds. [BC048248] KLA 1.00 1.01 1.05 1.00 1.03 .97 1.06
ATP .98 1.00 1.00 .96 1.03 1.05 1.04
KLA/ATP .98 1.08 .99 1.04 1.06 1.02 1.05
Gria2
KLA  ATP  ATP+KLA
 NM_013540 glutamate receptor, ionotropic, AMPA2 (alpha 2) (Gria2), transcript variant 2, mRNA [NM_013540] KLA 1.02 1.02 .98 1.01 .98 1.02 1.01
ATP .95 1.01 .95 .99 1.09 1.02 1.09
KLA/ATP 1.06 .92 .96 .99 1.00 1.03 1.00
Gria3
KLA  ATP  ATP+KLA
 AK161163 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831401I16 product:glutamate receptor, ionotropic, AMPA3 (alpha 3), full insert sequence. [AK161163] KLA 1.01 .96 .97 .95 .99 .84 .81
ATP 1.05 1.04 1.07 .86 .88 .84 .65
KLA/ATP .94 .95 1.06 .83 .79 .75 .66
Gria3
KLA  ATP  ATP+KLA
 NM_016886 glutamate receptor, ionotropic, AMPA3 (alpha 3) (Gria3), mRNA [NM_016886] KLA 1.04 .95 1.05 .98 .98 .97 .95
ATP 1.00 1.08 1.01 .97 .93 .98 .97
KLA/ATP 1.03 .93 .93 .98 .96 1.03 .89
Gria4
KLA  ATP  ATP+KLA
 NM_019691 glutamate receptor, ionotropic, AMPA4 (alpha 4) (Gria4), transcript variant 1, mRNA [NM_019691] KLA 1.05 1.05 1.00 .97 1.00 1.04 1.01
ATP 1.01 1.03 1.24 .99 .95 .99 1.02
KLA/ATP .99 1.03 1.04 1.00 .98 .97 1.02
Grik1
KLA  ATP  ATP+KLA
 NM_010348 glutamate receptor, ionotropic, kainate 1 (Grik1), transcript variant 2, mRNA [NM_010348] KLA 1.04 1.05 .99 1.03 .99 1.04 .89
ATP .98 1.06 1.02 .94 .94 1.01 1.08
KLA/ATP 1.07 .95 1.00 .97 1.05 .97 1.03
Grik1
KLA  ATP  ATP+KLA
 NM_146072 glutamate receptor, ionotropic, kainate 1 (Grik1), transcript variant 1, mRNA [NM_146072] KLA 1.00 .98 .99 1.04 .98 .96 .94
ATP .97 .96 1.03 1.02 .94 .94 .97
KLA/ATP .93 1.02 1.01 1.02 1.01 .97 1.02
Grik2
KLA  ATP  ATP+KLA
 NM_010349 glutamate receptor, ionotropic, kainate 2 (beta 2) (Grik2), transcript variant 2, mRNA [NM_010349] KLA 1.04 .99 .97 1.02 1.02 .99 .98
ATP 1.02 1.02 .99 .99 1.01 .98 .96
KLA/ATP .98 1.01 1.03 1.00 .96 .98 1.03
Grik3
KLA  ATP  ATP+KLA
 NM_001081097 glutamate receptor, ionotropic, kainate 3 (Grik3), mRNA [NM_001081097] KLA .97 .98 1.00 1.07 1.08 1.05 .98
ATP 1.00 .98 .98 .99 .98 1.03 1.02
KLA/ATP 1.01 .98 1.06 1.07 .97 1.04 1.03
Grik4
KLA  ATP  ATP+KLA
 NM_175481 glutamate receptor, ionotropic, kainate 4 (Grik4), mRNA [NM_175481] KLA 1.00 1.01 1.01 1.11 1.00 .95 1.03
ATP 1.05 1.02 1.00 1.00 1.12 .91 1.06
KLA/ATP .96 1.01 1.04 .99 .98 1.00 1.05
Grik5
KLA  ATP  ATP+KLA
 NM_008168 glutamate receptor, ionotropic, kainate 5 (gamma 2) (Grik5), mRNA [NM_008168] KLA .88 .88 .91 .89 .86 .87 .87
ATP 1.01 1.03 .97 1.06 .83 .73 .83
KLA/ATP .91 .87 .95 .92 .80 .77 .92
Grin1
KLA  ATP  ATP+KLA
 NM_008169 glutamate receptor, ionotropic, NMDA1 (zeta 1) (Grin1), mRNA [NM_008169] KLA .90 .97 .91 .98 .93 .94 1.01
ATP 1.04 1.04 1.02 1.08 .96 .91 .93
KLA/ATP .90 .99 .95 .95 .94 .88 .89
Grin2a
KLA  ATP  ATP+KLA
 NM_008170 glutamate receptor, ionotropic, NMDA2A (epsilon 1) (Grin2a), mRNA [NM_008170] KLA 1.00 1.08 1.00 1.03 1.09 1.02 1.04
ATP .96 .94 1.00 .98 1.03 .97 1.01
KLA/ATP .95 1.02 1.03 .95 .99 .99 .95
Grin2b
KLA  ATP  ATP+KLA
 NM_008171 glutamate receptor, ionotropic, NMDA2B (epsilon 2) (Grin2b), mRNA [NM_008171] KLA 1.03 1.02 1.10 1.09 1.02 1.03 1.08
ATP 1.15 1.07 1.05 1.07 1.08 1.04 1.02
KLA/ATP 1.10 1.04 1.07 1.13 1.09 1.08 1.06
Grin2c
KLA  ATP  ATP+KLA
 NM_010350 glutamate receptor, ionotropic, NMDA2C (epsilon 3) (Grin2c), mRNA [NM_010350] KLA 1.09 1.13 1.19 1.24 1.14 1.15 1.09
ATP 1.05 .96 .98 .98 .94 1.01 1.10
KLA/ATP 1.08 1.14 1.09 1.05 1.05 .98 1.01
Grin2d
KLA  ATP  ATP+KLA
 NM_008172 glutamate receptor, ionotropic, NMDA2D (epsilon 4) (Grin2d), mRNA [NM_008172] KLA 1.57 1.18 1.35 1.45 1.25 1.49 .91
ATP .92 .99 1.45 1.66 1.54 2.02 1.15
KLA/ATP 1.23 1.38 2.08 2.28 1.92 2.53 1.92
Grin3a
KLA  ATP  ATP+KLA
 AK044171 10 days neonate cortex cDNA, RIKEN full-length enriched library, clone:A830097C19 product:similar to IONOTROPIC GLUTAMATE RECEPTOR NMDA subunit NR3A[Rattus norvegicus], full insert sequence. [AK044171] KLA 1.06 1.00 .93 .95 .97 .97 .99
ATP .96 .97 1.02 .94 1.03 1.02 1.03
KLA/ATP 1.05 .96 1.05 .98 .94 1.02 1.03
Grin3b
KLA  ATP  ATP+KLA
 NM_130455 glutamate receptor, ionotropic, NMDA3B (Grin3b), mRNA [NM_130455] KLA .90 .92 .88 .98 .91 .91 .69
ATP .96 .93 .94 .92 .93 .84 .68
KLA/ATP .92 .88 .88 .95 .96 .88 .68
Grm1
KLA  ATP  ATP+KLA
 NM_016976 glutamate receptor, metabotropic 1 (Grm1), transcript variant 1, mRNA [NM_016976] KLA 1.16 1.07 1.10 1.18 1.08 1.04 1.15
ATP 1.06 1.05 1.02 .99 1.00 1.09 1.02
KLA/ATP 1.04 1.12 1.06 1.11 1.10 1.32 1.35
Grm2
KLA  ATP  ATP+KLA
 AK015353 adult male testis cDNA, RIKEN full-length enriched library, clone:4930441L02 product:unclassifiable, full insert sequence [AK015353] KLA 1.01 1.07 1.07 1.07 .99 .97 .98
ATP 1.03 1.05 .96 1.04 1.02 .90 .94
KLA/ATP 1.05 1.08 1.02 .99 .94 .98 1.01
Grm2
KLA  ATP  ATP+KLA
 XM_001475814 gb|PREDICTED: Mus musculus G protein-coupled receptor, family C, group 1, member B (Grm2), mRNA [XM_001475814] KLA 1.01 1.02 .94 .98 1.01 .99 .99
ATP 1.03 1.01 1.03 1.03 1.05 1.01 1.03
KLA/ATP 1.02 .97 1.05 1.00 .98 1.02 1.08
Grm3
KLA  ATP  ATP+KLA
 NM_181850 glutamate receptor, metabotropic 3 (Grm3), mRNA [NM_181850] KLA .95 1.00 1.00 1.01 .96 .99 .99
ATP .97 1.02 .99 1.08 1.05 1.02 1.04
KLA/ATP 1.00 .98 .99 1.07 1.07 1.03 1.04
Grm4
KLA  ATP  ATP+KLA
 NM_001013385 glutamate receptor, metabotropic 4 (Grm4), mRNA [NM_001013385] KLA .94 .97 .98 1.01 1.01 1.02 1.08
ATP .99 .94 1.03 .98 .95 .98 1.07
KLA/ATP .99 1.02 .93 1.00 1.02 1.03 1.05
Grm5
KLA  ATP  ATP+KLA
 NM_001081414 glutamate receptor, metabotropic 5 (Grm5), mRNA [NM_001081414] KLA 1.04 1.05 1.04 1.04 1.02 1.01 1.05
ATP .99 1.02 1.03 1.01 .99 1.00 1.03
KLA/ATP 1.03 1.02 1.02 1.03 1.01 1.01 1.05
Grm6
KLA  ATP  ATP+KLA
 BC034118 cDNA clone IMAGE:4511841, containing frame-shift errors [BC034118] KLA 1.00 .92 .99 1.02 .95 1.02 1.04
ATP 1.01 1.01 .99 .94 .94 .98 1.06
KLA/ATP .99 .99 1.01 1.02 1.00 .93 .91
Grm7
KLA  ATP  ATP+KLA
 NM_177328 glutamate receptor, metabotropic 7 (Grm7), mRNA [NM_177328] KLA .97 1.05 .96 1.05 1.02 1.01 1.02
ATP 1.02 .99 1.02 .97 1.00 1.04 1.01
KLA/ATP 1.00 1.00 .96 1.03 1.02 1.00 1.02
Grm8
KLA  ATP  ATP+KLA
 NM_008174 glutamate receptor, metabotropic 8 (Grm8), mRNA [NM_008174] KLA .98 .97 1.01 1.06 .99 .95 1.02
ATP 1.09 1.07 1.10 1.05 1.04 1.02 1.07
KLA/ATP 1.03 1.06 1.06 1.05 1.07 1.10 .93
Homer1
KLA  ATP  ATP+KLA
 NM_011982 homer homolog 1 (Drosophila) (Homer1), transcript variant S, mRNA [NM_011982] KLA 3.55 4.33 5.01 4.76 3.94 2.54 1.41
ATP 1.06 1.13 1.28 1.61 1.25 2.65 3.01
KLA/ATP 3.84 4.75 4.32 4.80 3.23 4.98 3.33
Homer1
KLA  ATP  ATP+KLA
 NM_152134 homer homolog 1 (Drosophila) (Homer1), transcript variant d, mRNA [NM_152134] KLA 3.58 3.92 4.44 3.82 2.90 1.95 1.37
ATP 1.13 1.08 1.04 1.08 1.02 1.21 1.52
KLA/ATP 3.77 4.28 2.88 3.17 2.79 2.45 1.76
Homer2
KLA  ATP  ATP+KLA
 NM_011983 homer homolog 2 (Drosophila) (Homer2), mRNA [NM_011983] KLA 1.02 1.02 1.03 .98 1.04 1.05 1.00
ATP .97 1.02 1.02 1.00 .98 1.02 .95
KLA/ATP .97 1.00 .98 1.00 .99 .95 .98
Homer3
KLA  ATP  ATP+KLA
 NM_011984 homer homolog 3 (Drosophila) (Homer3), mRNA [NM_011984] KLA 1.22 1.23 1.23 1.09 1.01 1.00 .96
ATP 1.05 1.17 1.24 1.53 1.48 1.84 1.20
KLA/ATP 1.20 1.35 1.24 1.23 1.16 1.29 1.46
Itpr1
KLA  ATP  ATP+KLA
 NM_010585 inositol 1,4,5-triphosphate receptor 1 (Itpr1), mRNA [NM_010585] KLA 3.66 3.69 6.74 8.11 7.08 4.40 1.22
ATP 1.08 .95 1.19 .94 1.09 1.00 .68
KLA/ATP 3.48 3.58 5.86 6.03 4.01 2.31 .97
Itpr2
KLA  ATP  ATP+KLA
 NM_019923 inositol 1,4,5-triphosphate receptor 2 (Itpr2), transcript variant 1, mRNA [NM_019923] KLA 1.41 1.38 1.43 1.42 1.30 1.07 1.01
ATP 1.00 1.00 .97 .97 1.07 1.15 1.06
KLA/ATP 1.39 1.48 1.64 1.42 1.07 .83 .95
Itpr3
KLA  ATP  ATP+KLA
 NM_080553 inositol 1,4,5-triphosphate receptor 3 (Itpr3), mRNA [NM_080553] KLA .55 .51 .45 .41 .34 .34 .45
ATP 1.01 .92 1.02 .57 .46 .34 1.22
KLA/ATP .56 .48 .48 .29 .33 .27 .65
Kcnj3
KLA  ATP  ATP+KLA
 BC068167 potassium inwardly-rectifying channel, subfamily J, member 3, mRNA (cDNA clone MGC:92970 IMAGE:30543982), complete cds [BC068167] KLA .99 .97 1.01 .94 .97 .99 .99
ATP 1.06 1.01 1.03 .82 1.01 1.00 .94
KLA/ATP .98 .91 .99 .99 1.01 1.11 .97
Kcnj3
KLA  ATP  ATP+KLA
 NM_008426 potassium inwardly-rectifying channel, subfamily J, member 3 (Kcnj3), mRNA [NM_008426] KLA 1.05 .99 1.04 1.02 1.02 1.04 .94
ATP 1.00 1.01 1.02 .99 .96 1.03 1.04
KLA/ATP 1.00 .98 1.03 1.02 1.02 .96 1.06
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mm.29656
0
KLA  ATP  ATP+KLA
 34328321 Unknown KLA 1.41 1.37 1.50 1.48 1.35 1.43 1.21
ATP 1.00 1.08 1.22 1.42 1.23 1.22 1.23
KLA/ATP 1.41 1.48 1.57 1.61 1.50 1.56 1.51
Mm.30102
KLA  ATP  ATP+KLA
 142348692 Unknown KLA 1.04 1.04 .97 1.07 1.02 .93 .90
ATP 1.06 .98 1.13 1.06 1.30 1.19 .78
KLA/ATP .94 1.05 1.13 1.05 1.24 1.12 .84
Mm.32259
4
KLA  ATP  ATP+KLA
 144922605 Unknown KLA 1.02 1.03 .98 .98 .95 1.00 1.02
ATP 1.01 .98 1.08 1.01 1.04 1.01 .97
KLA/ATP .97 1.08 1.04 1.02 1.00 1.01 1.03
Mm.33050
7
KLA  ATP  ATP+KLA
 67906182 Unknown KLA .94 .98 .99 1.03 1.05 1.07 .98
ATP .95 1.02 .97 .98 .99 1.05 1.02
KLA/ATP 1.02 1.05 1.01 1.03 .99 .98 .97
Mm.33138
9
KLA  ATP  ATP+KLA
 158508469 Unknown KLA .80 .79 .81 .82 .72 .64 .50
ATP .95 .85 .56 .48 .30 .33 .46
KLA/ATP .71 .64 .50 .41 .33 .32 .42
Mm.36036
8
KLA  ATP  ATP+KLA
 149257271 Unknown KLA 1.05 1.05 1.03 1.07 1.02 1.06 1.12
ATP 1.02 .93 1.03 1.01 .97 .91 1.09
KLA/ATP .99 1.10 1.08 1.03 .95 .97 1.10
Mm.41137
KLA  ATP  ATP+KLA
 148747308 Unknown KLA 1.03 1.00 .95 .92 1.04 .98 .96
ATP 1.02 .98 .98 .90 .95 .92 1.07
KLA/ATP .91 .89 1.01 .95 1.00 .96 .99
Mm.44009
5
KLA  ATP  ATP+KLA
 166158133 Unknown KLA .99 1.03 1.07 1.00 1.07 1.07 1.06
ATP .98 1.01 .98 .94 1.06 .96 .95
KLA/ATP 1.04 1.05 1.00 .97 1.06 .99 .95
Mm.44046
5
KLA  ATP  ATP+KLA
 164607131 Unknown KLA .65 .56 .59 .51 .33 .20 .24
ATP 1.07 .90 1.30 2.88 3.61 4.46 1.07
KLA/ATP .60 .59 .95 2.38 2.99 2.31 .37
Mm.44050
5
KLA  ATP  ATP+KLA
 84579905 Unknown KLA 1.03 .96 .90 1.03 .94 1.15 1.23
ATP .88 .91 1.15 1.18 1.17 1.31 1.02
KLA/ATP .87 .97 1.19 1.18 1.36 1.34 1.25
Mm.44160
1
KLA  ATP  ATP+KLA
 145966786 Unknown KLA 1.08 .94 1.01 .97 .79 .78 .71
ATP 1.09 .92 1.10 .75 .65 .92 .69
KLA/ATP 1.01 .92 1.16 .81 .69 .56 .63
Mm.44741
5
KLA  ATP  ATP+KLA
 40254195 Unknown KLA .92 .90 1.00 .88 .89 .84 .92
ATP .94 .95 1.07 .92 .83 .88 1.24
KLA/ATP .83 .94 1.03 .95 .89 .90 .91
Pla2g4a
KLA  ATP  ATP+KLA
 NM_008869 phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] KLA 3.93 4.49 4.86 6.40 6.44 3.10 1.68
ATP 1.13 1.36 1.27 1.30 1.02 5.37 1.47
KLA/ATP 3.64 4.45 4.76 7.11 2.96 4.08 2.60
Pla2g4b
KLA  ATP  ATP+KLA
 NM_145378 phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] KLA 1.09 1.18 .95 1.01 .97 .97 .77
ATP 1.05 1.14 1.28 .94 .88 1.18 .70
KLA/ATP 1.23 1.43 1.21 1.02 1.15 1.16 .78
Pla2g4c
KLA  ATP  ATP+KLA
 AK145339 1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] KLA 1.09 1.21 1.33 1.17 1.26 1.30 1.05
ATP .97 1.06 1.00 .98 .98 .98 1.05
KLA/ATP 1.19 1.16 1.18 1.13 1.04 1.02 1.06
Pla2g4c
KLA  ATP  ATP+KLA
 NM_001004762 phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] KLA .93 1.00 .94 .93 .94 .94 .96
ATP .98 .96 1.13 .97 .99 .89 .96
KLA/ATP 1.01 1.01 1.07 1.01 .94 1.01 .92
Pla2g4e
KLA  ATP  ATP+KLA
 AK049063 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] KLA 1.03 1.09 1.01 1.01 1.06 .94 1.05
ATP 1.03 1.00 1.06 1.01 .96 1.05 1.05
KLA/ATP .98 1.00 1.01 .98 1.03 .95 1.01
Pla2g4e
KLA  ATP  ATP+KLA
 NM_177845 phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] KLA .97 .95 1.01 .97 1.02 1.03 1.05
ATP .98 .99 1.00 1.10 .98 1.00 1.02
KLA/ATP 1.05 .93 .96 1.03 1.08 1.05 .99
Pla2g4f
KLA  ATP  ATP+KLA
 NM_001024145 phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] KLA 1.08 .99 1.04 1.02 1.04 .98 1.01
ATP .99 1.04 .99 1.03 1.12 1.01 1.25
KLA/ATP .97 1.04 1.10 1.06 1.04 1.03 1.03
Plcb1
KLA  ATP  ATP+KLA
 AK129166 mRNA for mKIAA0581 protein [AK129166] KLA 1.02 .98 .91 .91 .92 .95 .89
ATP 1.03 1.02 1.02 1.01 .90 1.02 1.04
KLA/ATP .98 .97 .91 .93 .92 1.01 1.16
Plcb1
KLA  ATP  ATP+KLA
 NM_019677 phospholipase C, beta 1 (Plcb1), mRNA [NM_019677] KLA .99 .94 .95 .97 .93 .92 .91
ATP 1.00 .96 .99 .95 .99 1.03 .98
KLA/ATP .93 .96 .94 .93 .87 1.00 1.06
Plcb2
KLA  ATP  ATP+KLA
 NM_177568 phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] KLA .70 .68 .64 .67 .65 .76 .88
ATP .95 .94 1.04 .94 .72 .57 1.19
KLA/ATP .69 .68 .72 .63 .65 .55 .70
Plcb3
KLA  ATP  ATP+KLA
 NM_008874 phospholipase C, beta 3 (Plcb3), mRNA [NM_008874] KLA 1.72 1.78 1.82 1.65 1.67 1.44 1.21
ATP .97 1.04 .81 .87 .78 .88 .94
KLA/ATP 1.69 1.89 1.44 1.66 1.12 .73 .93
Plcb4
KLA  ATP  ATP+KLA
 AK082509 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230058B11 product:unclassifiable, full insert sequence. [AK082509] KLA 1.06 1.03 .97 .98 1.02 1.01 .99
ATP .99 1.07 1.09 .95 .97 .97 1.02
KLA/ATP .98 1.00 1.03 .96 1.02 .91 .98
Plcb4
KLA  ATP  ATP+KLA
 NM_013829 phospholipase C, beta 4 (Plcb4), mRNA [NM_013829] KLA .88 .94 .81 .82 .81 .86 1.01
ATP 1.00 1.01 .92 .93 .88 .85 .89
KLA/ATP .97 .94 .78 .80 .78 .86 .97
Pld1
KLA  ATP  ATP+KLA
 NM_008875 phospholipase D1 (Pld1), mRNA [NM_008875] KLA .71 .73 .67 .73 .88 .96 1.25
ATP .99 .88 .73 .68 .45 1.23 1.12
KLA/ATP .70 .67 .58 .59 .48 .91 1.48
Pld2
KLA  ATP  ATP+KLA
 NM_008876 phospholipase D2 (Pld2), mRNA [NM_008876] KLA .51 .54 .48 .51 .73 .79 1.02
ATP 1.06 1.10 .88 1.03 1.04 1.29 1.00
KLA/ATP .63 .52 .40 .57 .65 1.03 1.35
Ppp3ca
KLA  ATP  ATP+KLA
 NM_008913 protein phosphatase 3, catalytic subunit, alpha isoform (Ppp3ca), mRNA [NM_008913] KLA .76 .85 .81 .85 .73 .70 .52
ATP .96 .78 .55 .46 .31 .33 .48
KLA/ATP .74 .64 .52 .42 .37 .36 .45
Ppp3cb
KLA  ATP  ATP+KLA
 AK135203 12 days embryo male wolffian duct includes surrounding region cDNA, RIKEN full-length enriched library, clone:6720421K10 product:protein phosphatase 3, catalytic subunit, beta isoform, full insert sequence. [AK135203] KLA 1.74 1.57 1.91 1.59 1.47 1.26 1.40
ATP 1.17 1.03 1.30 1.00 .81 .62 1.37
KLA/ATP 1.68 1.70 1.91 1.37 1.09 .47 1.13
Ppp3cb
KLA  ATP  ATP+KLA
 AK171904 activated spleen cDNA, RIKEN full-length enriched library, clone:F830018L06 product:Protein phosphatase 3 catalytic subunit beta3 (EC 3.1.3.16) (Serine [AK171904] KLA 1.29 1.29 1.21 1.15 1.22 1.13 1.28
ATP .90 .86 .80 .98 .94 .73 .92
KLA/ATP 1.06 1.03 .77 1.04 .92 .68 .90
Ppp3cb
KLA  ATP  ATP+KLA
 NM_008914 protein phosphatase 3, catalytic subunit, beta isoform (Ppp3cb), mRNA [NM_008914] KLA 1.21 1.29 1.38 1.24 1.29 1.08 1.23
ATP 1.15 1.31 1.09 1.29 .86 .60 .64
KLA/ATP 1.33 1.40 1.04 1.28 .79 .58 .73
Ppp3cc
KLA  ATP  ATP+KLA
 AK037563 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130026K22 product:unclassifiable, full insert sequence [AK037563] KLA 1.27 1.18 1.21 1.15 1.01 .92 1.36
ATP .96 1.09 1.10 1.03 .85 1.06 1.47
KLA/ATP 1.17 1.24 1.07 1.13 .91 .88 1.36
Ppp3cc
KLA  ATP  ATP+KLA
 NM_008915 protein phosphatase 3, catalytic subunit, gamma isoform (Ppp3cc), mRNA [NM_008915] KLA 1.64 1.81 1.79 1.35 .90 .70 1.31
ATP .90 .90 1.13 .93 .86 1.40 1.60
KLA/ATP 1.45 1.62 1.74 1.47 1.04 1.01 1.31
Ppp3r1
KLA  ATP  ATP+KLA
 NM_024459 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) (Ppp3r1), mRNA [NM_024459] KLA 1.02 1.17 .93 1.27 1.15 1.30 1.30
ATP .97 .95 .77 .91 .99 1.18 1.10
KLA/ATP 1.12 1.04 .88 1.00 1.10 1.10 1.07
Ppp3r2
KLA  ATP  ATP+KLA
 NM_001004025 protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type II) (Ppp3r2), mRNA [NM_001004025] KLA 1.03 1.05 1.06 1.08 1.12 1.05 1.04
ATP 1.00 1.02 1.04 1.04 .99 .99 1.01
KLA/ATP 1.04 1.12 1.03 1.09 1.00 .99 1.00
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkca
KLA  ATP  ATP+KLA
 NM_011101 protein kinase C, alpha (Prkca), mRNA [NM_011101] KLA 1.00 .96 .94 .95 .95 .89 .96
ATP 1.00 1.03 .91 .94 .82 .87 1.13
KLA/ATP 1.02 .95 .91 .86 .78 .84 .94
Prkcb1
KLA  ATP  ATP+KLA
 NM_008855 protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] KLA .92 .95 .93 .78 .77 1.08 1.83
ATP 1.03 1.12 1.09 1.23 .90 2.08 .96
KLA/ATP .98 .99 .82 .89 .62 1.01 1.08
Prkcc
KLA  ATP  ATP+KLA
 NM_011102 protein kinase C, gamma (Prkcc), mRNA [NM_011102] KLA 1.02 1.04 1.11 1.04 .96 1.02 1.05
ATP .98 .98 1.05 1.03 1.08 .96 .95
KLA/ATP 1.21 1.16 1.09 1.07 1.04 .98 .93
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Shank1
KLA  ATP  ATP+KLA
 XM_001473991 gb|PREDICTED: Mus musculus SH3 [XM_001473991] KLA 1.13 1.05 1.13 1.12 1.00 1.01 1.03
ATP .98 .96 1.09 1.07 1.03 1.06 .93
KLA/ATP 1.05 1.20 1.13 1.05 1.03 .97 1.03
Shank2
KLA  ATP  ATP+KLA
 NM_001113373 SH3/ankyrin domain gene 2 (Shank2), transcript variant 2, mRNA [NM_001113373] KLA 1.01 .96 .99 1.00 1.07 .97 1.02
ATP .97 1.01 1.00 1.14 .89 1.00 1.08
KLA/ATP 1.10 .95 .97 1.00 1.04 1.00 1.06
Slc17a6
KLA  ATP  ATP+KLA
 NM_080853 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 (Slc17a6), mRNA [NM_080853] KLA .97 1.03 1.05 .98 1.02 1.06 1.08
ATP .98 1.00 .97 1.05 1.01 1.01 1.02
KLA/ATP 1.01 1.01 .96 1.02 .96 .98 .97
Slc17a7
KLA  ATP  ATP+KLA
 NM_182993 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 7 (Slc17a7), mRNA [NM_182993] KLA .98 1.03 1.00 1.01 1.04 1.02 .96
ATP .97 .97 1.06 1.05 .96 .97 1.02
KLA/ATP .95 1.02 .90 1.05 1.04 1.03 1.01
Slc17a8
KLA  ATP  ATP+KLA
 NM_182959 solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (Slc17a8), mRNA [NM_182959] KLA 1.18 1.13 1.21 1.14 1.21 1.09 1.11
ATP 1.02 .96 1.07 1.08 1.14 1.14 1.21
KLA/ATP 1.12 1.24 1.14 1.10 1.12 1.22 1.50
Slc1a1
KLA  ATP  ATP+KLA
 NM_009199 solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 (Slc1a1), mRNA [NM_009199] KLA 1.07 1.09 1.07 1.11 1.05 1.03 .98
ATP 1.01 1.00 .99 1.04 1.25 1.28 1.05
KLA/ATP 1.12 1.03 1.09 1.09 1.07 1.07 1.22
Slc1a2
KLA  ATP  ATP+KLA
 NM_001077514 solute carrier family 1 (glial high affinity glutamate transporter), member 2 (Slc1a2), transcript variant 1, mRNA [NM_001077514] KLA 1.07 1.09 1.17 1.09 1.16 1.09 1.05
ATP 1.06 .99 .99 1.01 1.08 1.22 1.19
KLA/ATP 1.10 1.10 1.10 1.06 1.12 1.16 1.28
Slc1a2
KLA  ATP  ATP+KLA
 NM_011393 solute carrier family 1 (glial high affinity glutamate transporter), member 2 (Slc1a2), transcript variant 3, mRNA [NM_011393] KLA 1.07 1.07 1.01 1.12 1.12 1.21 1.12
ATP .96 1.01 1.02 1.09 1.10 1.21 1.22
KLA/ATP 1.05 1.12 1.06 1.02 1.18 1.22 1.36
Slc1a3
KLA  ATP  ATP+KLA
 AK046688 4 days neonate male adipose cDNA, RIKEN full-length enriched library, clone:B430312B09 product:unclassifiable, full insert sequence. [AK046688] KLA .96 1.04 1.07 1.01 1.06 1.07 1.09
ATP 1.01 1.02 1.00 1.04 1.08 1.07 1.04
KLA/ATP 1.05 1.00 1.00 1.12 1.10 1.09 1.03
Slc1a3
KLA  ATP  ATP+KLA
 NM_148938 solute carrier family 1 (glial high affinity glutamate transporter), member 3 (Slc1a3), mRNA [NM_148938] KLA .99 1.03 1.03 1.01 .98 .99 1.02
ATP 1.02 1.03 1.00 1.04 .96 .97 1.06
KLA/ATP .95 .95 .96 .97 .98 1.03 .99
Slc1a6
KLA  ATP  ATP+KLA
 NM_009200 solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 (Slc1a6), mRNA [NM_009200] KLA .96 1.00 1.04 1.12 .90 .91 .96
ATP 1.02 .94 .98 .99 .98 .94 .97
KLA/ATP .97 1.04 .99 .96 .99 .98 .91
Slc1a7
KLA  ATP  ATP+KLA
 NM_146255 solute carrier family 1 (glutamate transporter), member 7 (Slc1a7), mRNA [NM_146255] KLA .98 1.02 .99 1.06 1.05 1.03 1.08
ATP .98 .97 1.02 1.06 1.03 .98 1.01
KLA/ATP 1.01 1.02 1.11 1.10 1.01 1.05 .99
Slc38a1
KLA  ATP  ATP+KLA
 AK162429 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430020E10 product:hypothetical protein, full insert sequence [AK162429] KLA .93 .80 .66 .47 .37 .57 .84
ATP .92 .84 .94 1.58 1.58 .90 .50
KLA/ATP .87 .70 .62 .86 1.20 .96 .52
Slc38a1
KLA  ATP  ATP+KLA
 NM_134086 solute carrier family 38, member 1 (Slc38a1), mRNA [NM_134086] KLA 1.24 1.07 1.03 .84 .66 .71 .91
ATP .90 .83 1.17 1.64 1.92 1.39 .90
KLA/ATP 1.12 1.02 1.20 1.25 1.65 1.27 .99
Slc38a2
KLA  ATP  ATP+KLA
 AK164568 13 days embryo heart cDNA, RIKEN full-length enriched library, clone:D330050A21 product:solute carrier family 38, member 2, full insert sequence [AK164568] KLA .49 .44 .31 .39 .58 .67 .87
ATP 1.52 1.82 5.27 8.64 3.25 1.48 1.13
KLA/ATP .47 .68 1.28 2.77 2.02 .86 .76
Slc38a2
KLA  ATP  ATP+KLA
 NM_175121 solute carrier family 38, member 2 (Slc38a2), mRNA [NM_175121] KLA .45 .46 .38 .34 .33 .52 .73
ATP 1.04 1.22 1.93 5.44 5.96 3.34 1.39
KLA/ATP .45 .48 .58 1.67 2.62 1.71 .86
Slc38a3
KLA  ATP  ATP+KLA
 NM_023805 solute carrier family 38, member 3 (Slc38a3), mRNA [NM_023805] KLA 1.18 1.02 1.01 1.03 1.04 1.04 .99
ATP 1.01 .98 1.11 1.06 .99 1.05 1.06
KLA/ATP 1.02 1.03 1.15 1.07 1.04 .96 1.06
Trpc1
KLA  ATP  ATP+KLA
 AK038676 adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230054C16 product:transient receptor potential cation channel, subfamily C, member 1, full insert sequence. [AK038676] KLA .99 .96 1.07 1.00 1.03 .97 .95
ATP .99 1.01 1.03 1.01 1.01 1.04 .94
KLA/ATP .94 1.02 .95 .96 .97 .95 1.00
Trpc1
KLA  ATP  ATP+KLA
 NM_011643 transient receptor potential cation channel, subfamily C, member 1 (Trpc1), mRNA [NM_011643] KLA 1.06 1.05 .97 1.08 1.06 1.00 1.06
ATP 1.04 .93 .99 .97 .91 1.00 .94
KLA/ATP 1.04 1.04 .86 1.01 .97 .95 .96